| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |